Lead global teams designing, developing and characterizing products across multiple regulatory classifications: drug, supplements, foods, cosmetics, consumer goods.

Lead entrepreneur accountable for connecting global strategy, products and technologies with Nerve Care leaders in each region (LatAm, AMA, Europe, North America).Lead internal and external technology development (design, prototyping, product testing, manufacturing strategy)Design, program and deploy consumer studies; extract insights to identify unmet consumer needs

Accountable to Global HealthCare (Oral Care, Respiratory, Digestive Wellness, VMS) to deliver IP strategies that generate a portfolio of Exclusive and Superior innovations.

Accountable for developing strategy and delivering Vicks products to market through leadership of multi-functional R&D team and integration with Commercial team.• Innovate through fast-cycle consumer learning (prototype-test-improve)• Communicate technical challenges and timelines to non-technical Commercial/Finance partners• Evaluate cost/risk/reward structure of external development/manufacturing partnerships

Enabled delivery of largest Innovation Bundle in Vicks’ 115-year lifetimeLead personal and technical development of team of 10-15 Scientists• Drive executional excellence through implementation of Scrum methodology• Unleash team delivery of more methods (>30) in 4 months than the previous 4 years (24)• Eradicate technical debt through transparency and communication strategies with cross-functional partners (Process & Formulation, Products Research, Packaging, Safety, Regulatory)

Serve as analytical lead for over the counter (OTC) innovations. Partner with Technology Development to inform formulation decisions and with Product Researchers to impact consumer satisfaction.

Provide analytical expertise for upstream FEI projects. Develop and validate chromatographic methods for raw materials and OTC drug products. Define chemical vulnerability of new and existing API products and develop high efficiency stability indicating chromatographic analyses for identification and quantification.Investigate and implement new separation science capabilities.Simplify, update, translate and transfer LC methods from relatively low pressure HPLC systems (<400 bar) to UPLC and state of the art column technology.

Portfolio Focal Point for existing products and pipeline molecules: Modify and develop fast methods for analysis of active ingredients, impurities and co-formulants in formulations and technical grade active ingredients.Global Complaint Sample Analytical Focal Point: Analyze (qualitative and quantitative) customer complaint samples, manufacturing process failure samples, and potential counterfeit formulations. Deal directly with Quality function, commercial and customers to communicate results and ensure satisfaction.LC Strategy Leader for Analytical Center of Expertise: define and implement strategy for use, maintenance, growth of LC instrumentation. Collaborate with instrument vendors to ensure successful method development and method transfer to internal and external sites.

Development of new methods for the early detection of lung cancer using Liquid Chromatography Mass Spectrometry (LC-MS/MS) and Multiple Reaction Monitoring (MRM) MS.

Apply novel approaches to classic chromatography (GC, LC, CE, TLC) and develop unique nano-stationary phases to separate complicated mixtures.

Develop methods for arsenic quantitation and speciation using hydride generated atomic fluorescence spectroscopy (HG-AFS). Analyzed both forensic (hair) samples and vegetation samples.